Evidence map›Paper›PMID 37026171›Full record

Observational studyJournal of diabetes investigation2023

Independent risk factors of rapid glomerular filtration rate decline in patients with type 2 diabetes with preserved kidney function and normoalbuminuria: A multicenter cohort study.

Daishi Hirano, Hiroyuki Unoki-Kubota, Toshiyuki Imasawa, Ritsuko Yamamoto-Honda, Hiroshi Kajio, Shigeo Yamashita, Yuka Fukazawa, Naoto Seki, Mitsuhiko Noda, Yasushi Kaburagi

Open access · goldAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Journal of diabetes investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Daishi HiranoDepartment of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2398-5928
Hiroyuki Unoki-KubotaDepartment of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4827-8805
Toshiyuki ImasawaDepartment of Nephrology, National Hospital Organization Chiba-Higashi National Hospital, Chiba, Japan.ORCID https://orcid.org/0000-0002-6620-7069
Ritsuko Yamamoto-HondaHealth Management Center and Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan.
Hiroshi KajioDepartment of Diabetes, Endocrinology, and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.
Shigeo YamashitaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Tokyo Yamate Medical Center, Japan Community Health Care Organization, Tokyo, Japan.
Yuka FukazawaDepartment of Diabetes and Endocrinology, JR Tokyo General Hospital, Tokyo, Japan.
Naoto SekiDepartment of Diabetes and Endocrinology, National Hospital Organization Chiba-Higashi National Hospital, Chiba, Japan.
Mitsuhiko NodaDepartment of Diabetes, Metabolism and Endocrinology, Ichikawa Hospital, International University of Health and Welfare, Chiba, Japan.ORCID https://orcid.org/0000-0003-0413-4631
Yasushi KaburagiDepartment of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
National Center for Global Health and Medicine · JPChiba East Hospital · JPInternational University of Health and Welfare · JPJikei University School of Medicine · JPJR Tokyo General Hospital · JPTokyo Yamate Medical Center · JPToranomon Hospital · JP

Funding

AMED JP22ym0126805Grants for National Center for Global Health and Medicine 19A1007Grants for National Center for Global Health and Medicine 26S104Grants for National Center for Global Health and Medicine 30S2004Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan H20-009Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan H25-016JSPS KAKENHI 19K08717
6 · The paper itself

Abstract

AIMS/

introductionResearch on the incidence and underlying mechanisms of rapid renal function decline in patients with type 2 diabetes mellitus with preserved renal function and normoalbuminuria is limited. This study aimed to investigate the involvement of hemoglobin level as a risk factor for rapid decliners among patients with type 2 diabetes with preserved renal function and normoalbuminuria. MATERIALS AND

methodsThis was a retrospective observational study of 242 patients with type 2 diabetes with a baseline estimated glomerular filtration rate of ≥60 mL/min/1.73 m

resultsThe median follow-up period was 6.7 years, and 34 patients showed rapid decliners. On multivariate analysis, lower baseline hemoglobin level was a risk factor of rapid decliners (odds ratio 0.69, 95% confidence interval 0.47-0.99; P = 0.045). Furthermore, the baseline hemoglobin levels were correlated positively with iron and ferritin levels, implying that an impaired iron metabolism might cause lower hemoglobin levels in rapid decliners.

conclusionsIn patients with type 2 diabetes with preserved renal function and normoalbuminuria, lower hemoglobin levels were a risk factor for rapid decliners, where disturbed iron metabolism might precede the development of diabetic kidney disease.

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesAlbuminuriaDisease ProgressionGlomerular Filtration RateHemoglobinsHumansKidneyRetrospective StudiesRisk FactorsHemoglobinsEstimated glomerular filtration rateHemoglobin levelKidney function decline

Identifiers

PMID37026171
PMCPMC10286785
OpenAlexW4362692166

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.